Sweden
· Delayed Price · Currency is SEK Vitrolife AB Statistics
Total Valuation
Vitrolife AB has a market cap or net worth of SEK 18.31 billion. The enterprise value is 19.38 billion.
| Market Cap | 18.31B |
| Enterprise Value | 19.38B |
Important Dates
The last earnings date was Thursday, July 17, 2025.
| Earnings Date | Jul 17, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Vitrolife AB has 135.42 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 135.42M |
| Shares Outstanding | 135.42M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 64.19% |
| Float | 75.04M |
Valuation Ratios
The trailing PE ratio is 40.35 and the forward PE ratio is 31.12. Vitrolife AB's PEG ratio is 2.61.
| PE Ratio | 40.35 |
| Forward PE | 31.12 |
| PS Ratio | 5.17 |
| PB Ratio | 1.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 33.97 |
| P/OCF Ratio | 26.42 |
| PEG Ratio | 2.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.27, with an EV/FCF ratio of 35.96.
| EV / Earnings | 42.60 |
| EV / Sales | 5.47 |
| EV / EBITDA | 17.27 |
| EV / EBIT | 27.89 |
| EV / FCF | 35.96 |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.41 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.78 |
| Debt / FCF | 3.70 |
| Interest Coverage | 7.09 |
Financial Efficiency
Return on equity (ROE) is 3.45% and return on invested capital (ROIC) is 2.85%.
| Return on Equity (ROE) | 3.45% |
| Return on Assets (ROA) | 2.58% |
| Return on Invested Capital (ROIC) | 2.85% |
| Return on Capital Employed (ROCE) | 4.29% |
| Revenue Per Employee | 3.09M |
| Profits Per Employee | 396,687 |
| Employee Count | 1,169 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 3.63 |
Taxes
In the past 12 months, Vitrolife AB has paid 156.00 million in taxes.
| Income Tax | 156.00M |
| Effective Tax Rate | 25.53% |
Stock Price Statistics
The stock price has decreased by -39.36% in the last 52 weeks. The beta is 1.78, so Vitrolife AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -39.36% |
| 50-Day Moving Average | 142.97 |
| 200-Day Moving Average | 181.07 |
| Relative Strength Index (RSI) | 37.23 |
| Average Volume (20 Days) | 89,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitrolife AB had revenue of SEK 3.54 billion and earned 455.00 million in profits. Earnings per share was 3.35.
| Revenue | 3.54B |
| Gross Profit | 2.08B |
| Operating Income | 695.00M |
| Pretax Income | 611.00M |
| Net Income | 455.00M |
| EBITDA | 1.07B |
| EBIT | 695.00M |
| Earnings Per Share (EPS) | 3.35 |
Balance Sheet
The company has 921.00 million in cash and 1.99 billion in debt, giving a net cash position of -1.07 billion or -7.92 per share.
| Cash & Cash Equivalents | 921.00M |
| Total Debt | 1.99B |
| Net Cash | -1.07B |
| Net Cash Per Share | -7.92 |
| Equity (Book Value) | 13.28B |
| Book Value Per Share | 98.07 |
| Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was 693.00 million and capital expenditures -154.00 million, giving a free cash flow of 539.00 million.
| Operating Cash Flow | 693.00M |
| Capital Expenditures | -154.00M |
| Free Cash Flow | 539.00M |
| FCF Per Share | 3.98 |
Margins
Gross margin is 58.85%, with operating and profit margins of 19.63% and 12.85%.
| Gross Margin | 58.85% |
| Operating Margin | 19.63% |
| Pretax Margin | 17.26% |
| Profit Margin | 12.85% |
| EBITDA Margin | 30.30% |
| EBIT Margin | 19.63% |
| FCF Margin | 15.22% |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.81%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 0.81% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 32.83% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 0.71% |
| Earnings Yield | 2.49% |
| FCF Yield | 2.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 17, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Vitrolife AB has an Altman Z-Score of 4.9 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.9 |
| Piotroski F-Score | 8 |